All News #Library
Biotech
OS Therapies Acquires Advaxis Immuno Assets from Ayala Pharma
09 Apr 2025 //
BUSINESSWIRE
OS Therapies Acquires Ayala’s Listeria Immuno-Oncology Assets
29 Jan 2025 //
BUSINESSWIRE
GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for GIGA-564
06 Nov 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support